Metformin aggravates immune-mediated liver injury in mice

Archives of Toxicology

Volumn 89, Issue 3, 2015, Pages 437-450

  Volarevic, Vladislav ^a   Misirkic, Maja ^b   Vucicevic, Ljubica ^b   Paunovic, Verica ^b   Simovic Markovic, Bojana ^a   Stojanovic, Maja ^b   Milovanovic, Marija ^a   Jakovljevic, Vladimir ^a   Micic, Dragan ^b   Arsenijevic, Nebojsa ^a   Trajkovic, Vladimir ^b   Lukic, Miodrag L ^a  

^a UNIVERSITY OF KRAGUJEVAC   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Apoptosis; Autophagy; Concanavalin A; Hepatitis; Metformin; T lymphocytes

Indexed keywords

ANTIDIABETIC AGENT; CONCANAVALIN A; CYTOKINE; METFORMIN;

ANIMAL; APOPTOSIS; AUTOPHAGY; BAGG ALBINO MOUSE; C57BL MOUSE; DRUG EFFECTS; DRUG-INDUCED LIVER INJURY; FLOW CYTOMETRY; IMMUNOLOGY; LIVER; LIVER CELL; MALE; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

ANIMALS; APOPTOSIS; AUTOPHAGY; CONCANAVALIN A; CYTOKINES; DRUG-INDUCED LIVER INJURY; FLOW CYTOMETRY; HEPATOCYTES; HYPOGLYCEMIC AGENTS; LIVER; MALE; METFORMIN; MICE, INBRED BALB C; MICE, INBRED C57BL; REAL-TIME POLYMERASE CHAIN REACTION; T-LYMPHOCYTES;

EID: 84939886726     PISSN: 03405761     EISSN: 14320738     Source Type: Journal    
DOI: 10.1007/s00204-014-1263-1     Document Type: Article

References (54)

1. Ajuebor MN, Hogaboam CM, Le T, Swain MG (2003) C–C chemokine ligand 2/monocyte chemoattractant protein-1 directly inhibits NKT cell IL-4 production and is hepatoprotective in T cell-mediated hepatitis in the mouse. J Immunol 170:5252–5259
2. Bhamra GS, Hausenloy DJ, Davidson SM, Carr RD, Paiva M, Wynne AM, Mocanu MM, Yellon DM (2008) Metformin protects the ischemic heart by the Akt-mediated inhibition of mitochondrial permeability transition pore opening. Basic Res Cardiol 103:274–284
3. Blagih J, Krawczyk CM, Jones RG (2012) LKB1 and AMPK: central regulators of lymphocyte metabolism and function. Immunol Rev 249:59–71
4. Boyle JG, Salt IP, McKay GA (2010) Metformin action on AMP-activated protein kinase: a translational research approach to understanding a potential new therapeutic target. Diabet Med 27:1097–1106
5. Brahmachari S, Pahan K (2009) Suppression of regulatory T cells by IL-12p40 homodimer via nitric oxide. J Immunol 183:2045–2058
6. Chang CP, Yang MC, Lei HY (2011) Concanavalin A/IFN-gamma triggers autophagy-related necrotic hepatocyte death through IRGM1-mediated lysosomal membrane disruption. PLoS ONE 6:e28323
7. Chau-Van C, Gamba M, Salvi R, Gaillard RC, Pralong FP (2007) Metformin inhibits adenosine 5′-monophosphate-activated kinase activation and prevents increases in neuropeptide Y expression in cultured hypothalamic neurons. Endocrinology 148:507–511
8. Cone CJ, Bachyrycz AM, Murata GH (2010) Hepatotoxicity associated with metformin therapy in treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease. Ann Pharmacother 44:1655–1659
9. Cosgrove BD, Alexopoulos LG, Hang TC, Hendriks BS, Sorger PK, Griffith LG, Lauffenburger DA (2010) Cytokine-associated drug toxicity in human hepatocytes is associated with signaling network dysregulation. Mol BioSyst 6:1195–1206
10. de la Poza GomezG, Rivero Fernandez M, Vazquez Romero M, Angueira Lapena T, Arranz de la Mata G, Boixeda de Miquel D (2008) Constitutional syndrome associated to metformin induced hepatotoxicity. Gastroenterol Hepatol 31:643–645
11. Eisenberg-Lerner A, Bialik S, Simon HU, Kimchi A (2009) Life and death partners: apoptosis, autophagy and the cross-talk between them. Cell Death Differ 16:966–975
12. Erhardt A, Wegscheid C, Claass B, Carambia A, Herkel J, Mittrucker HW, Panzer U, Tiegs G (2011) CXCR3 deficiency exacerbates liver disease and abrogates tolerance in a mouse model of immune-mediated hepatitis. J Immunol 186:5284–5293
13. Graham GG, Punt J, Arora M, Day RO, Doogue MP, Duong JK, Furlong TJ, Greenfield JR, Greenup LC, Kirkpatrick CM, Ray JE, Timmins P, Williams KM (2011) Clinical pharmacokinetics of metformin. Clin Pharmacokinet 50:81–98
14. Han Y, Guo Q, Zhang M, Chen Z, Cao X (2009) CD69 + CD4 + CD25 − T cells, a new subset of regulatory T cells, suppress T cell proliferation through membrane-bound TGF-beta 1. J Immunol 182:111–120
15. Hsieh PS, Hsieh YJ (2011) Impact of liver diseases on the development of type 2 diabetes mellitus. World J Gastroenterol 17:5240–5245
16. Ichimura Y, Komatsu M (2010) Selective degradation of p62 by autophagy. Semin Immunopathol 32:431–436
17. Isakovic A, Harhaji L, Stevanovic D, Markovic Z, Sumarac-Dumanovic M, Starcevic V, Micic D, Trajkovic V (2007) Dual antiglioma action of metformin: cell cycle arrest and mitochondria-dependent apoptosis. Cell Mol Life Sci 64:1290–1302
18. Isoda K, Young JL, Zirlik A, MacFarlane LA, Tsuboi N, Gerdes N, Schonbeck U, Libby P (2006) Metformin inhibits proinflammatory responses and nuclear factor-kappaB in human vascular wall cells. Arterioscler Thromb Vasc Biol 26:611–617
19. Kaneko Y, Harada M, Kawano T, Yamashita M, Shibata Y, Gejyo F, Nakayama T, Taniguchi M (2000) Augmentation of Valpha14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis. J Exp Med 191:105–114
20. Kato Y, Koide N, Komatsu T, Tumurkhuu G, Dagvadorj J, Kato K, Yokochi T (2010) Metformin attenuates production of nitric oxide in response to lipopolysaccharide by inhibiting MyD88-independent pathway. Horm Metab Res 42:632–636
21. Kimura T, Takabatake Y, Takahashi A, Isaka Y (2013) Chloroquine in cancer therapy: a double-edged sword of autophagy. Cancer Res 73:3–7
22. Kusters S, Gantner F, Kunstle G, Tiegs G (1996) Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A. Gastroenterology 111:462–471
23. Lee SW, Choi H, Eun SY, Fukuyama S, Croft M (2011) Nitric oxide modulates TGF-beta-directive signals to suppress Foxp3 + regulatory T cell differentiation and potentiate Th1 development. J Immunol 186:6972–6980
24. Li WC, Ralphs KL, Tosh D (2010) Isolation and culture of adult mouse hepatocytes. Methods Mol Biol 633:185–196
25. Miljkovic D, Trajkovic V (2004) Inducible nitric oxide synthase activation by interleukin-17. Cytokine Growth Factor Rev 15:21–32
26. Miralles-Linares F, Puerta-Fernandez S, Bernal-Lopez MR, Tinahones FJ, Andrade RJ, Gomez-Huelgas R (2012) Metformin-induced hepatotoxicity. Diabetes Care 35:e21
27. Nath N, Khan M, Paintlia MK, Singh I, Hoda MN, Giri S (2009) Metformin attenuated the autoimmune disease of the central nervous system in animal models of multiple sclerosis. J Immunol 182:8005–8014
28. Olivera-Gonzalez S, de Escalante-Yanguela B, Velilla-Soriano C, Amores-Arriaga B, Martin-Fortea P, Navarro-Aguilar ME (2010) Metformin-associated hepatotoxicity. Med Intensiva 34:483–487
29. Pearce EL, Walsh MC, Cejas PJ, Harms GM, Shen H, Wang LS, Jones RG, Choi Y (2009) Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature 460:103–107
30. Pilon G, Dallaire P, Marette A (2004) Inhibition of inducible nitric-oxide synthase by activators of AMP-activated protein kinase: a new mechanism of action of insulin-sensitizing drugs. J Biol Chem 279:20767–20774
31. Prandota J (2005) Important role of proinflammatory cytokines/other endogenous substances in drug-induced hepatotoxicity: depression of drug metabolism during infections/inflammation states, and genetic polymorphisms of drug-metabolizing enzymes/cytokines may markedly contribute to this pathology. Am J Ther 12:254–261
32. Rao KM (2000) Molecular mechanisms regulating iNOS expression in various cell types. J Toxicol Environ Health B Crit Rev 3:27–58
33. Rautou PE, Mansouri A, Lebrec D, Durand F, Valla D, Moreau R (2010) Autophagy in liver diseases. J Hepatol 53:1123–1134
34. Santodomingo-Garzon T, Swain MG (2011) Role of NKT cells in autoimmune liver disease. Autoimmun Rev 10:793–800
35. Sass G, Koerber K, Bang R, Guehring H, Tiegs G (2001) Inducible nitric oxide synthase is critical for immune-mediated liver injury in mice. J Clin Invest 107:439–447
36. Siendones E, Fouad D, Abou-Elella AM, Quintero A, Barrera P, Muntane J (2003) Role of nitric oxide in D-galactosamine-induced cell death and its protection by PGE1 in cultured hepatocytes. Nitric Oxide 8:133–143
37. Smith-Garvin JE, Koretzky GA, Jordan MS (2009) T cell activation. Annu Rev Immunol 27:591–619
38. Sridharan S, Jain K, Basu A (2011) Regulation of autophagy by kinases. Cancers 3:2630–2654
39. Stevanovic D, Janjetovic K, Misirkic M, Vucicevic L, Sumarac-Dumanovic M, Micic D, Starcevic V, Trajkovic V (2012) Intracerebroventricular administration of metformin inhibits ghrelin-induced Hypothalamic AMP-kinase signalling and food intake. Neuroendocrinology 96:24–31
40. Teshima S, Nakanishi H, Nishizawa M, Kitagawa K, Kaibori M, Yamada M, Habara K, Kwon AH, Kamiyama Y, Ito S, Okumura T (2004) Up-regulation of IL-1 receptor through PI3 K/Akt is essential for the induction of iNOS gene expression in hepatocytes. J Hepatol 40:616–623
41. Tiegs G, Hentschel J, Wendel A (1992) A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J Clin Invest 90:196–203
42. Tomic T, Botton T, Cerezo M, Robert G, Luciano F, Puissant A, Gounon P, Allegra M, Bertolotto C, Bereder JM, Tartare-Deckert S, Bahadoran P, Auberger P, Ballotti R, Rocchi S (2011) Metformin inhibits melanoma development through autophagy and apoptosis mechanisms. Cell Death Dis 2:e199
43. Torisu T, Nakaya M, Watanabe S, Hashimoto M, Yoshida H, Chinen T, Yoshida R, Okamoto F, Hanada T, Torisu K, Takaesu G, Kobayashi T, Yasukawa H, Yoshimura A (2008) Suppressor of cytokine signaling 1 protects mice against concanavalin A-induced hepatitis by inhibiting apoptosis. Hepatology 47:1644–1654
44. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3:RESEARCH0034
45. Volarevic V, Milovanovic M, Ljujic B, Pejnovic N, Arsenijevic N, Nilsson U, Leffler H, Lukic ML (2012a) Galectin-3 deficiency prevents concanavalin A-induced hepatitis in mice. Hepatology 55:1954–1964
46. Volarevic V, Mitrovic M, Milovanovic M, Zelen I, Nikolic I, Mitrovic S, Pejnovic N, Arsenijevic N, Lukic ML (2012b) Protective role of IL-33/ST2 axis in Con A-induced hepatitis. J Hepatol 56:26–33
47. Wang HX, Liu M, Weng SY, Li JJ, Xie C, He HL, Guan W, Yuan YS, Gao J (2012) Immune mechanisms of Concanavalin A model of autoimmune hepatitis. World J Gastroenterol 18:119–125
48. Xie Z, Lau K, Eby B, Lozano P, He C, Pennington B, Li H, Rathi S, Dong Y, Tian R, Kem D, Zou MH (2011) Improvement of cardiac functions by chronic metformin treatment is associated with enhanced cardiac autophagy in diabetic OVE26 mice. Diabetes 60:1770–1778
49. Yang Z, Klionsky DJ (2010) Mammalian autophagy: core molecular machinery and signaling regulation. Curr Opin Cell Biol 22:124–131
50. Yang YM, Han CY, Kim YJ, Kim SG (2010) AMPK-associated signaling to bridge the gap between fuel metabolism and hepatocyte viability. World J Gastroenterol 16:3731–3742
51. Yuan H, Li L, Zheng W, Wan J, Ge P, Li H, Zhang L (2012) Antidiabetic drug metformin alleviates endotoxin-induced fulminant liver injury in mice. Int Immunopharmacol 12:682–688
52. Zhou F, Ajuebor MN, Beck PL, Le T, Hogaboam CM, Swain MG (2005) CD154-CD40 interactions drive hepatocyte apoptosis in murine fulminant hepatitis. Hepatology 42:372–380
53. Zhu R, Diem S, Araujo LM, Aumeunier A, Denizeau J, Philadelphe E, Damotte D, Samson M, Gourdy P, Dy M, Schneider E, Herbelin A (2007) The Pro-Th1 cytokine IL-12 enhances IL-4 production by invariant NKT cells: relevance for T cell-mediated hepatitis. J Immunol 178:5435–5442
54. Zhu J, Feng A, Sun J, Jiang Z, Zhang G, Wang K, Hu S, Qu X (2011) Increased CD4(+) CD69(+) CD25(−) T cells in patients with hepatocellular carcinoma are associated with tumor progression. J Gastroenterol Hepatol 26:1519–1526